397 related articles for article (PubMed ID: 10319383)
21. Primary splenic B-cell lymphoma (marginal zone lymphoma). Clinicopathological evaluation of 10 cases.
Maryniak RK; Prochorec-Sobieszek M
Pol J Pathol; 2000; 51(4):185-90. PubMed ID: 11247389
[TBL] [Abstract][Full Text] [Related]
22. Composite splenic marginal zone lymphoma and mantle cell lymphoma arising from 2 independent B-cell clones.
Lefebvre C; Fabre B; Vettier C; Rabin L; Florin A; Wang J; Gressin R; Jacob MC; Callanan M; Leroux D
Hum Pathol; 2007 Apr; 38(4):660-7. PubMed ID: 17134739
[TBL] [Abstract][Full Text] [Related]
23. Splenic diffuse red pulp small-B cell lymphoma: toward the emergence of a new lymphoma entity.
Traverse-Glehen A; Baseggio L; Salles G; Coiffier B; Felman P; Berger F
Discov Med; 2012 Apr; 13(71):253-65. PubMed ID: 22541613
[TBL] [Abstract][Full Text] [Related]
24. Leukemic meningitis in a patient with splenic lymphoma with villous lymphocytes (SLVL). Meningitis as a possible initial manifestation of SLVL.
Yamazaki K; Shimizu S; Negami T; Sawada K; Nanasawa H; Ohta M; Konda S; Okuda K
Cancer; 1994 Jul; 74(1):61-5. PubMed ID: 8004584
[TBL] [Abstract][Full Text] [Related]
25. Deletion mapping on the long arm of chromosome 7 in splenic lymphoma with villous lymphocytes.
Gruszka-Westwood AM; Hamoudi R; Osborne L; Matutes E; Catovsky D
Genes Chromosomes Cancer; 2003 Jan; 36(1):57-69. PubMed ID: 12461750
[TBL] [Abstract][Full Text] [Related]
26. Splenic marginal zone lymphoma with or without villous lymphocytes. Hematologic findings and outcomes in a series of 57 patients.
Iannitto E; Ambrosetti A; Ammatuna E; Colosio M; Florena AM; Tripodo C; Minardi V; Calvaruso G; Mitra ME; Pizzolo G; Menestrina F; Franco V
Cancer; 2004 Nov; 101(9):2050-7. PubMed ID: 15389479
[TBL] [Abstract][Full Text] [Related]
27. Relevance of a scoring system including CD11c expression in the identification of splenic diffuse red pulp small B-cell lymphoma (SRPL).
Baseggio L; Traverse-Glehen A; Callet-Bauchu E; Morel D; Magaud JP; Berger F; Salles G; Felman P
Hematol Oncol; 2011 Mar; 29(1):47-51. PubMed ID: 20677173
[TBL] [Abstract][Full Text] [Related]
28. CD27 distinguishes two phases in bone marrow infiltration of splenic marginal zone lymphoma.
Franco V; Florena AM; Ascani S; Paulli M; Salvato M; Pileri SA
Histopathology; 2004 Apr; 44(4):381-6. PubMed ID: 15049905
[TBL] [Abstract][Full Text] [Related]
29. [Lymphoma of the marginal zone of the spleen. A case study].
Navarro JT; Ribera JM; Pérez-Piteira J; Vaquero M; Zarco MA; Juncá J; Granada I; Millá F; Feliu E
Med Clin (Barc); 1996 Feb; 106(4):141-3. PubMed ID: 8948931
[TBL] [Abstract][Full Text] [Related]
30. The morphologic spectrum of non-Hodgkin's lymphomas with BCL1/cyclin D1 gene rearrangements.
Swerdlow SH; Zukerberg LR; Yang WI; Harris NL; Williams ME
Am J Surg Pathol; 1996 May; 20(5):627-40. PubMed ID: 8619427
[TBL] [Abstract][Full Text] [Related]
31. CD45 expression in low-grade B-cell non-Hodgkin's lymphomas.
Carulli G; Cannizzo E; Zucca A; Buda G; Orciuolo E; Marini A; Petrini M
Leuk Res; 2008 Feb; 32(2):263-7. PubMed ID: 17692374
[TBL] [Abstract][Full Text] [Related]
32. Splenic large B-cell lymphoma in patients with hepatitis C virus infection.
Takeshita M; Sakai H; Okamura S; Oshiro Y; Higaki K; Nakashima O; Uike N; Yamamoto I; Kinjo M; Matsubara F
Hum Pathol; 2005 Aug; 36(8):878-85. PubMed ID: 16112004
[TBL] [Abstract][Full Text] [Related]
33. Comparative study of marginal zone lymphoma involving bone marrow.
Kent SA; Variakojis D; Peterson LC
Am J Clin Pathol; 2002 May; 117(5):698-708. PubMed ID: 12090417
[TBL] [Abstract][Full Text] [Related]
34. Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features.
Kanellis G; Mollejo M; Montes-Moreno S; Rodriguez-Pinilla SM; Cigudosa JC; Algara P; Montalban C; Matutes E; Wotherspoon A; Piris MA
Haematologica; 2010 Jul; 95(7):1122-9. PubMed ID: 20220064
[TBL] [Abstract][Full Text] [Related]
35. Histopathologic features of splenic small B-cell lymphomas. A study of 42 cases with a definitive diagnosis by the World Health Organization classification.
Kansal R; Ross CW; Singleton TP; Finn WG; Schnitzer B
Am J Clin Pathol; 2003 Sep; 120(3):335-47. PubMed ID: 14502797
[TBL] [Abstract][Full Text] [Related]
36. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders.
Cabezudo E; Carrara P; Morilla R; Matutes E
Haematologica; 1999 May; 84(5):413-8. PubMed ID: 10329919
[TBL] [Abstract][Full Text] [Related]
37. Splenic lymphoma with villous lymphocytes.
Gupta R; Naseem S; Sukumaran S; Kashyap R; Kaur S; Paul L
Indian J Pathol Microbiol; 2008; 51(1):113-5. PubMed ID: 18417879
[TBL] [Abstract][Full Text] [Related]
38. [Differential malignant lymphoproliferative syndrome (LPS) diagnosis with flow cytometry: a study of 100 patients].
Cardile N; Sabo G; Butsch P; Brengarth E; Viollier AF; Knecht H
Praxis (Bern 1994); 2000 Jan; 89(4):143-9. PubMed ID: 10686807
[TBL] [Abstract][Full Text] [Related]
39. Primary splenic lymphoma: does it exist?
Gobbi PG; Grignani GE; Pozzetti U; Bertoloni D; Pieresca C; Montagna G; Ascari E
Haematologica; 1994; 79(3):286-93. PubMed ID: 7926983
[TBL] [Abstract][Full Text] [Related]
40. Non-Hodgkin's lymphoproliferative disorders involving the spleen.
Arber DA; Rappaport H; Weiss LM
Mod Pathol; 1997 Jan; 10(1):18-32. PubMed ID: 9021723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
